MAP
AVNS

Moody Aldrich Partners’s Avanos Medical AVNS Stock Holding History

Moody Aldrich Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-93,736
Closed -$4.09M – 124
2019
Q2 		$4.09M Buy
93,736
+2,530
+3% +$108K 1.04% 37
2019
Q1 		$3.89M Buy
91,206
+15,607
+21% +$699K 1.09% 43
2018
Q4 		$3.39M Sell
75,599
-7,641
-9% -$400K 1.11% 40
2018
Q3 		$5.7M Buy
+83,240
New +$5.36M 1.64% 16

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moody Aldrich Partners's AVNS Position: Q3 2019 in Review

Moody Aldrich Partners sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 93,736 shares — an estimated $4.09M sold.

Moody Aldrich Partners first reported a position in AVNS in Q3 2018 and held it in 4 quarters. The position peaked at $5.7M in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Moody Aldrich Partners reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Moody Aldrich Partners sold 93,736 Avanos Medical shares in Q3 2019, an estimated $4.09M.
  • Moody Aldrich Partners first reported a position in Avanos Medical in Q3 2018 and held it in 4 quarters.
  • Moody Aldrich Partners's Avanos Medical position peaked at $5.7M in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Moody Aldrich Partners's 13F filing for Q3 2019, filed 12 Nov 2019.